Outcome Measure | Transversus Abdominis Plane (n = 47) | Control (n = 52) | P Value |
MME consumption | |||
POD 0 MME | 19.0 (11.0–36.0) | 32.5 (21.3–42.8) | 0.004a |
POD 1 MME | 58.7 (36.0–75.0) | 61.5 (45.1–79.3) | 0.129 |
POD 2 MME | 45.0 (23.5–75.0) | 60.0 (35.3–81.1) | 0.147 |
POD 3 MME | 42.5 (12.0–60.0) | 45.0 (17.1–75.0) | 0.476 |
POD 4 MME | 0.0 (0.0–46.0) | 9.6 (0.0–63.0) | 0.459 |
POD 5 MME | 0.0 (0.0–27.5) | 0.0 (0.0–32.5) | 0.268 |
Length of stay, d | 4.0 (3.0–5.0) | 4.0 (3.0–5.0) | 0.811 |
Total MME days | |||
0–2 | 124.0 (86.4–173.0) | 151.1 (113.0–196.2) | 0.036a |
0–5 | 190.0 (115.0–262.0) | 240.7 (157.7–345.6) | 0.050a |
Abbreviations: MME, morphine milligram equivalents; POD, postoperative day.
Note: Data presented as median (interquartile range).
↵a Statistically significant difference (P < 0.05).